Previous 10 | Next 10 |
home / stock / bvnry / bvnry news
Bavarian Nordic A/S ADR (BVNRY) is expected to report $0.31 for Q3 2023
2023-09-01 12:45:33 ET More on Bavarian Nordic Bavarian Nordic A/S ( OTCPK:BVNKF ) Q2 2023 Earnings Call Transcript Bavarian Nordic receives $120m contract for manufacturing of smallpox and mpox vaccine from U.S. government Bavarian Nordic monkeypox vaccine Jynne...
2023-08-23 13:42:08 ET Bavarian Nordic A/S (BVNKF) Q2 2023 Earnings Conference Call August 23, 2023 8:00 AM ET Company Participants Rolf Sass Sorensen - Vice President Investor Relations Paul Chaplin - President and Chief Executive Officer Jean-Christophe May - E...
2023-08-03 11:36:25 ET Bavarian Nordic A/S ( OTCPK:BVNRY ) shares up nearly 5% on Thursday after it received $120M contract from the U.S. Government for manufacturing of smallpox and mpox vaccine. The order, representing $96M of the contract value, will be manufactu...
2023-07-21 05:42:00 ET Summary Today, we take a look at a life sciences company called Emergent BioSolutions. The company is making a big bet on the NARCAN marketplace, selling one business and getting FDA approval for a new OTC product. An investment analysis around Emergent ...
NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Deutsche Bank Depositary Receipts Virtual Investor Conference (“dbVIC”) held on May 16 th and 17 th are now...
2023-05-14 14:12:09 ET Call Start: 08:00 Call End: 08:50 Bavarian Nordic A/S (BVNKF) Q1 2023 Earnings Conference Call May 9, 2023 08:00 ET Company Participants Rolf Sorensen - Investor Relations Paul Chaplin - President & Chief Executive Officer Henri...
NEW YORK, May 09, 2023 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday May16 and Wednesday, May17, featuring live webcast presentations from international companies with American Depositary Rec...
Bavarian Nordic A/S (BVNKF) Q4 2022 Earnings Conference Call March 02, 2023, 08:00 AM ET Company Participants Rolf Sorensen - Investor Relations Henrik Juuel - Executive Vice President, CFO Paul Chaplin - President and Chief Executive Officer Conference Call Part...
GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that it has entered into an agreement to sell its travel health business to Bavarian Nordic (BVNRY) for a total value of up to $380 million, including potential future milestone payments. Under ...
News, Short Squeeze, Breakout and More Instantly...
Bavarian Nordic A/S ADR Company Name:
BVNRY Stock Symbol:
OTCMKTS Market:
Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...
Greif Inc. Class A (GEF) is expected to report $1.3 for Q4 2023 Skandinaviska Enskilda Banken - Class A (SVKEF) is expected to report for Q3 2023 Yellow Corporation (YELLQ) is expected to report for Q3 2023 Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Lakeland Industrie...
Addex Therapeutics Ltd (ADXN) is expected to report $-4 for Q3 2023 Eco Wave Power Global AB (publ) (WAVE) is expected to report for quarter end 2023-09-30 AmeraMex International, Inc. (AMMX) is expected to report for Q3 2023 iClick Interactive Asia Group Limited (ICLK) is expected to...